AI assistant
Edwards Lifesciences Corp — Director's Dealing 2012
Jul 30, 2012
30042_dirs_2012-07-30_537154ed-8486-496f-b3cf-9129842ad560.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Edwards Lifesciences Corp (EW)
CIK: 0001099800
Period of Report: 2012-07-27
Reporting Person: REINDL ROBERT C (CVP, H.R. and Communications)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-07-27 | Common Stock | M | 54000.0000 | $21.9550 | Acquired | 58588.0000 | Direct |
| 2012-07-27 | Common Stock | S | 300.0000 | $105.8000 | Disposed | 58288.0000 | Direct |
| 2012-07-27 | Common Stock | S | 3088.0000 | $103.0600 | Disposed | 55200.0000 | Direct |
| 2012-07-27 | Common Stock | S | 3464.0000 | $102.6200 | Disposed | 51736.0000 | Direct |
| 2012-07-27 | Common Stock | S | 10311.0000 | $103.9800 | Disposed | 41425.0000 | Direct |
| 2012-07-27 | Common Stock | S | 40301.0000 | $105.2600 | Disposed | 1124.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-07-27 | Employee Stock Option (Right to Acquire) | $21.9550 | M | 54000.0000 | Disposed | 2013-05-10 | Common Stock (54000.0000) | Direct |
Footnotes
F1: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.
F2: This transaction was executed in multiple trades at prices ranging from $102.62 to $103.53. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3: This transaction was executed in multiple trades at prices ranging from $103.64 to $104.39. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4: This transaction was executed in multiple trades at prices ranging from $104.77 to $105.74. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.